Also mentions Berkeley:
NIPS retrospective
x hide permanently

Genpact Launches AI Based Solution in Drug Safety Automation

genpact.com

Press Release Genpact Launches an Artificial Intelligence (AI)-Based Solution to Usher in a New Era of Drug Safety Automation Genpact’s new Pharmacovigilance Artificial Intelligence (“PVAI”) solution promises to transform drug safety data management and reporting NEW YORK, June 12, 2017 – Genpact (NYSE: G), a global professional services firm focused on delivering digital transformation for clients, is investing in leading digital technologies that are transforming industries.

Mentions: Berkeley Palo Alto New York